MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biomedicines14030585

Медицинская библиотека · Biomedicines · 2026

Novel Antiplasmodial Natural Products Identified Through a Modified Bioluminescence-Based Rate-of-Kill Assay.

Mobley Rebecca, Nasser Suzanne A, Bartholomew Barbara, Nash Robert, Horrocks Paul, Price Helen

СтатьяПеревод в очереди

Аннотация

Background/

Objectives

The discovery of antimalarial compounds with novel mechanisms of action and distinct rates of kill (RoK) is essential to address emerging drug resistance in Plasmodium falciparum. Natural product libraries represent a valuable and chemically diverse source of potential new antiplasmodial scaffolds. This study aimed (i) to evaluate a modified bioluminescence relative rate-of-kill (mBRRoK) assay as a rapid triage platform for screening large compound libraries with previously unknown antiplasmodial activity, enabling simultaneous assessment of potency and RoK, and (ii) to identify novel compounds with potent and selective in vitro erythrocytic activity.

Methods

A fixed two-concentration mBRRoK screen was applied to 1165 compounds from the PhytoQuest natural product library. Antiplasmodial activity and RoK profiles were assessed over 48 h using two genetically distinct luciferase-expressing P. falciparum strains (Dd2luc and NF54luc) with distinct drug resistance backgrounds. Reproducibility was evaluated across biological replicates. Selected hits underwent secondary profiling, including EC50 determination and HepG2 cytotoxicity assessment to establish potency and selectivity.

Results

The primary screen identified 36 lead compounds demonstrating potent activity within 48 h, encompassing both fast- and slow-acting phenotypes. Activity was reproducible and largely strain-independent across both parasite lines. Secondary profiling prioritised four compounds (100657, 101158, 101160, and 101173) with nanomolar-to-micromolar antiplasmodial potency and favourable selectivity indices relative to mammalian cell cytotoxicity.

Conclusions

The mBRRoK assay provides a robust and scalable framework for integrating potency and pharmacodynamic assessment in early antimalarial discovery. This strategy enabled efficient prioritisation of selective natural product-derived leads with distinct killing profiles, supporting their progression toward further optimisation and preclinical development.

Для цитирования: Mobley Rebecca, Nasser Suzanne A, Bartholomew Barbara, Nash Robert, Horrocks Paul, Price Helen. Novel Antiplasmodial Natural Products Identified Through a Modified Bioluminescence-Based Rate-of-Kill Assay.. Biomedicines. 2026. DOI: 10.3390/biomedicines14030585.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.